Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Priveterra Acquisition Reports Authorization To List On NYSE Upon Completion Of Business Combination With AEON Biopharma

Author: Benzinga Newsdesk | July 17, 2023 04:04pm

AEON will be a wholly owned subsidiary of Priveterra and Priveterra will change its name to AEON Biopharma, Inc. Trading is expected to begin on NYSE on July 24, 2023, under the new ticker symbol "AEON" for the New AEON Common Stock following the consummation of the Business Combination, which is expected to occur on July 21, 2023

Posted In: AEON PMGM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist